Results 31 to 40 of about 1,774 (156)
Extensively Drug-Resistant New Delhi Metallo-β-Lactamase–Encoding Bacteria in the Environment, Dhaka, Bangladesh, 2012 [PDF]
Emerging Infectious Diseases, 2015 Carriage of the New Delhi metallo-β-lactamase variant 1 (NDM-1) enables drug resistance to move between communities and hospitals. In Bangladesh, we found the blaNDM-1 gene in 62% of environmental waters and in fermentative and nonfermentative gram ...
Mark A. Toleman +2 more
doaj +2 more sources
Emergence of blaNDM-5 and blaOXA-232 Positive Colistin- and Carbapenem-Resistant Klebsiella pneumoniae in a Bulgarian Hospital [PDF]
AntibioticsThe rapid spread of carbapenemase-producing strains has led to increased levels of resistance among Gram-negative bacteria, especially enterobacteria. The current study aimed to collect and genetically characterize the colistin- and carbapenem-resistant ...
Rumyana Markovska +6 more
doaj +2 more sources
Genomic Characterization and Resistance Mechanisms of Carbapenem-Resistant <i>Klebsiella pneumoniae</i> ST101 Isolates from Saudi Arabia. [PDF]
Int J Mol SciCarbapenem-resistant Klebsiella pneumoniae (CRKP) represents a critical global health threat, with ST101 identified as a major circulating clone in Saudi Arabia. We used whole genome sequencing and plasmid reconstruction to investigate the molecular characteristics of CRKP ST101 isolates from Saudi Arabia (2018–2021), analyzing antimicrobial resistance
Idrees EK +11 more
europepmc +4 more sources
Spread of OXA-48 and NDM-1-Producing Klebsiella pneumoniae ST48 and ST101 in Chicken Meat in Western Algeria [PDF]
Microbial Drug Resistance, 2021 Aim: We investigated the prevalence of carbapenemase-producing Enterobacteriaceae (CPE) in chicken meat in Western Algeria in 2017. Results: From February to July 2017, samples of chicken meat from three poultry ...
Chaalal, Nadia +6 more
openaire +2 more sources
Emergence of carbapenemase-producing and colistin resistant Klebsiella pneumoniae ST101 high-risk clone in Turkey [PDF]
Acta Microbiologica et Immunologica Hungarica, 2020 AbstractCarbapenemase-producing and colistin resistant Klebsiella pneumoniae has become a worldwide healthcare problem. This study describes molecular characterization of carbapenemase-producing and colistin resistant clinical K. pneumoniae isolates.A total of 93 non-replicate carbapenem and colistin resistant K. pneumoniae were recovered from clinical
Gülşen Hazırolan, Alper Karagöz
openaire +3 more sources
Cells, 2023 Developing novel therapeutics often follows three steps: target identification, design of strategies to suppress target activity and drug development to implement the strategies.
Lloyd A. Greene +3 more
doaj +1 more source
, 2022 BackgroundKlebsiella pneumoniae ST101 is an emerging high-risk clone which exhibits extensive drug resistance. Bacterial strains residing in multiple hosts show unique signatures related to host adaptation.
Youri Glupczynski (106660) +6 more
core +1 more source
, 2022 BackgroundKlebsiella pneumoniae ST101 is an emerging high-risk clone which exhibits extensive drug resistance. Bacterial strains residing in multiple hosts show unique signatures related to host adaptation.
Youri Glupczynski (106660) +6 more
core +1 more source
Journal of Global Antimicrobial Resistance, 2021 : Objectives: The emergence and dissemination of colistin-resistant Enterobacterales has become a major global public-health threat. Here we investigated the genomic and phylogenetic characteristics of a multidrug-resistant Klebsiella pneumoniae strain (
Hangfei Chen +6 more
doaj +1 more source
, 2022 BackgroundKlebsiella pneumoniae ST101 is an emerging high-risk clone which exhibits extensive drug resistance. Bacterial strains residing in multiple hosts show unique signatures related to host adaptation.
Youri Glupczynski (106660) +6 more
core +1 more source